EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Drug–Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians

David M Burger iD, Laura Nijboer, Mira Ghobreyal, Johan Maertens, Nicole Blijlevens, Luuk Hilbrands, Marije C Baas, Per Ljungman, Roger J M Brüggemann iD

Clinical Pharmacokinetics · 2024-11 · 63 (11) · 1529-1546

DOI: 10.1007/s40262-024-01437-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 07.11.2024. Verfasst von David M Burger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Radboudumc Institute for Medical Innovation (RIMI), Radboudumc, Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands. dav…. Hauptthemen laut MEDLINE: Drug Interactions, Antiviral Agents, Benzimidazoles, Cytomegalovirus Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug InteractionsAntiviral AgentsBenzimidazolesCytomegalovirus InfectionsRibonucleosidesAcetatesQuinazolinesHumansDichlororibofuranosylbenzimidazole

Substanzen

letermovirAntiviral AgentsmaribavirBenzimidazolesRibonucleosidesAcetatesQuinazolinesDichlororibofuranosylbenzimidazole

Autor:innen und Institutionen

  • Department of Pharmacy, Radboudumc Institute for Medical Innovation (RIMI), Radboudumc, Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands. david.burger@radboudumc.nl.
  • Global DDI Solutions, Utrecht, The Netherlands. david.burger@radboudumc.nl.
  • Department of Pharmacy, Radboudumc Institute for Medical Innovation (RIMI), Radboudumc, Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands.
  • Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium.
  • Department of Haematology, University Hospitals Leuven, Leuven, Belgium.
  • Department of Hematology, Radboudumc, Nijmegen, The Netherlands.

ORCID-Profile: David M Burger, Roger J M Brüggemann

Zitieren

APA

Burger, D. M., Nijboer, L., Ghobreyal, M., Maertens, J., Blijlevens, N., Hilbrands, L., Baas, M. C., Ljungman, P., & Brüggemann, R. J. M. (2024). Drug–Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians. Clinical Pharmacokinetics, 63(11), 1529-1546. https://doi.org/10.1007/s40262-024-01437-5

Vancouver

Burger DM, Nijboer L, Ghobreyal M, Maertens J, Blijlevens N, Hilbrands L, et al. Drug–Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians. Clinical Pharmacokinetics. 2024;63(11):1529-1546. doi:10.1007/s40262-024-01437-5

BibTeX
@article{Burger2024,
  author = {Burger, David M and Nijboer, Laura and Ghobreyal, Mira and Maertens, Johan and Blijlevens, Nicole and Hilbrands, Luuk and Baas, Marije C and Ljungman, Per and Brüggemann, Roger J M},
  title = {Drug–Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians},
  journal = {Clinical Pharmacokinetics},
  year = {2024},
  volume = {63},
  number = {11},
  pages = {1529--1546},
  doi = {10.1007/s40262-024-01437-5}
}
Kostenlos starten →